Our in vivo data showed that MUC1 overexpression was associated with the higher growth rate of CIPp-MUC1 tumors, which suggested that MUC1 upregulation promoted the growth of canine mammary tumors in vivo. This evidence concerns the gene PATJ and breast cancer.